212 related articles for article (PubMed ID: 10650522)
21. [Protective effect of lithium oxybutyrate on the ischemic myocardium].
Chichkanov GG; Tsorin IB; Kirsanova GIu; Lomtadze DM
Biull Eksp Biol Med; 1988 Jan; 105(1):46-8. PubMed ID: 3337880
[TBL] [Abstract][Full Text] [Related]
22. [Dopamine enhancement of the cerebral microcirculation in a local ischemic lesion].
Topchian AV; Balasanian MG; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 1999; 62(6):29-31. PubMed ID: 10650523
[TBL] [Abstract][Full Text] [Related]
23. [The comparative efficacy of emoxipine and sodium oxybutyrate in experimental myocardial ischemia].
Afanas'ev SA; Alekseeva ED; Bardamova IB; Bogomaz SA
Eksp Klin Farmakol; 1994; 57(4):24-6. PubMed ID: 7950776
[TBL] [Abstract][Full Text] [Related]
24. [The effect of cytochrome c preparations on the cerebral circulation in cerebral ischemia].
Gatsura VV; Gaevyĭ MD; Davidov ER; Pogorelyĭ VE; Pyzhnyĭ VO
Eksp Klin Farmakol; 1994; 57(2):22-4. PubMed ID: 8205042
[TBL] [Abstract][Full Text] [Related]
25. [Effect of lithium oxybutyrate on lipid metabolic changes in pituitrin-induced pulmonary edema].
Kurygin GV; Chizhov PA
Biull Eksp Biol Med; 1988 Feb; 105(2):152-4. PubMed ID: 2450599
[TBL] [Abstract][Full Text] [Related]
26. [Neuroprotective and cerebrovascular effects of GABA mimetics].
Mirzoian RS
Eksp Klin Farmakol; 2003; 66(2):53-6. PubMed ID: 12962049
[TBL] [Abstract][Full Text] [Related]
27. [Effect of GABA and piracetam on cerebral circulation and the neurogenic mechanisms of its regulation].
Ivashev MN; Petrov VI; Shcherbakova TN
Farmakol Toksikol; 1984; 47(6):40-3. PubMed ID: 6519254
[TBL] [Abstract][Full Text] [Related]
28. [Effect of magnesium sulfate on characteristics of cerebral hemodynamics under conditions of postischemic brain injury].
Oleĭnikova ON; Makarova LM; Pogorelyĭ VE
Eksp Klin Farmakol; 2010 Sep; 73(9):17-9. PubMed ID: 21086647
[TBL] [Abstract][Full Text] [Related]
29. [Experimental study of the neurotropic activity of lithium oxybutyrate].
Liubimov BI; Tolmacheva NS; Ostrovskaia RU; Mitrofanov VS
Farmakol Toksikol; 1980; 43(3):273-6. PubMed ID: 7449964
[TBL] [Abstract][Full Text] [Related]
30. [The neuroprotective effect of GABA-ergic substances in cerebral ischemia].
Kulinskiĭ VI; Mikhel'son GV
Eksp Klin Farmakol; 1997; 60(1):56-8. PubMed ID: 9162288
[TBL] [Abstract][Full Text] [Related]
31. [Emoxipin as an inhibitor of angiogenesis].
Sologub AA; Akberova SI; Ziangirova GG
Biull Eksp Biol Med; 1992 Dec; 114(12):620-2. PubMed ID: 1284038
[TBL] [Abstract][Full Text] [Related]
32. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
[TBL] [Abstract][Full Text] [Related]
33. [The action of sodium oxybutyrate and emoxypin on the functional state of the adrenaline-damaged myocardium in an experiment].
Sysoliatina NA; Artamonova VV
Eksp Klin Farmakol; 1998; 61(2):30-2. PubMed ID: 9621170
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study of several preparations in different models of cerebral hypoxia].
Ivanova IA; Bobkov IuG
Biull Eksp Biol Med; 1984 Nov; 98(11):567-70. PubMed ID: 6509174
[TBL] [Abstract][Full Text] [Related]
35. [Possibility of restoring the cerebral blood flow in cerebral ischemia by injecting special polymers into the blood].
Gannushkina IV; Grigorian SS; Kameneva MV; Shakhnazarov AA
Patol Fiziol Eksp Ter; 1982; (3):58-9. PubMed ID: 7122140
[No Abstract] [Full Text] [Related]
36. [Lithium oxybutyrate correction of the circadian pattern of reserpine-induced depression].
Zamoshchina TA; Matveenko AV; Alekseeva LP; Agarkova VP; Saratikov AS
Patol Fiziol Eksp Ter; 1993; (4):22-4. PubMed ID: 8183609
[TBL] [Abstract][Full Text] [Related]
37. [Methodological approaches to the search for pharmacological agents effective in cerebral hypoxia and ischemia].
Bobkov IuG; Ivanova IA
Patol Fiziol Eksp Ter; 1987; (6):13-9. PubMed ID: 3444668
[No Abstract] [Full Text] [Related]
38. [Rhodiola rosea extract for prophylaxis of ischemic cerebral circulation disorder].
Pogorelyĭ VE; Makarova LM
Eksp Klin Farmakol; 2002; 65(4):19-22. PubMed ID: 12449069
[TBL] [Abstract][Full Text] [Related]
39. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
[TBL] [Abstract][Full Text] [Related]
40. [Cerebrovascular effects of GABA-prostaglandin E2 conjugate in comparison with prostaglandin E2].
Gorbunova AV; Gan'shina TS; Gretskaia NM; Bezuglov VV; Mirzoian RS
Eksp Klin Farmakol; 2013; 76(8):13-6. PubMed ID: 24228482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
